A R T I C L E S
McFarland et al.
Turbospray source and an Agilent 1100 series LC pump. Centrifu-
gation was conducted using a Legend Mach 1.6R Tabletop
Centrifuge (Sorvall, U.S.A.) or a RC 5C Plus Superspeed Centrifuge
(Sorvall, U.S.A.).
sufficiently large quantities for assignment. When possible, product
formation was quantified by ESI-LCMS after purification (Figure
S2, S3). The purification of the protein samples is described below.
Thioredoxin Modification Procedure for NMR Analysis. In
a 15 mL Falcon tube were combined 0.34 µmol of thioredoxin
(dissolved in 0.9 mL of 50 mM phosphate buffer, pH 6.5), 0.9 mL
of 100 mM phosphate buffer, pH 6.5, 6 mg of 4-aminophenethyl
alcohol dissolved in 18 µL of DMF, 5.4 µL of 13C-formaldehyde
(20% w/w in H2O), and 1 mg of TCEP (3 µmol). The solution was
mixed gently for 40 h at room temperature. Product formation could
not be observed by ESI-LCMS as the protein did not ionize well.
Expression and Purification of Thioredoxin. A wild-type
human thioredoxin clone was received as a gift from the group of
Professor Michael Marletta at the University of California, Berkeley.
Thioredoxin was expressed according to a modified literature
procedure.12 Tuner DE3pLysS competent cells (Novagen, U.S.A.)
were transformed with pET20b plasmid vector containing the
thioredoxin gene and an ampicillin resistance gene. All steps were
carried out under ampicillin (50 µg/mL) selection. Colonies were
selected for inoculation of Luria Broth cultures. When cultures
reached midlog phase as determined by OD600, expression was
induced by addition of 100 µM IPTG (Invitrogen, U.S.A.). Cultures
were grown for 4 h at 37 °C and then harvested by centrifugation.
Cell pellets were resuspended in lysis buffer (50 mM sodium
phosphate, 300 mM sodium chloride, 10 mM imidazole, 5%
glycerol, pH 8.0) and stored at -80 °C until further purification.
The cells were lysed by ultrasonification, and the resulting
cellular debris was pelleted by centrifugation. The supernatant was
applied to a nickel-nitrolotriacetic acid (Ni-NTA) (Qiagen, USA)
column. After loading, the column was washed with 20 volumes
of wash buffer (50 mM sodium phosphate, 500 mM sodium
chloride, 20 mM imidazole, 5% glycerol, pH 8.0), followed by 10
volumes of elution buffer (50 mM sodium phosphate, 500 mM
sodium chloride, 500 mM imidazole, 5% glycerol, pH 8.0).
Fractions containing the desired thioredoxin protein (as determined
by SDS-PAGE) were pooled and concentrated using spin concen-
trators (Amicon Ultra 15, MWCO 10k) (Millipore, USA). The
protein was further purified using a Sephadex S200 16/60 gel
filtration column equilibrated with 50 mM sodium phosphate, 300
mM sodium chloride, 100 µM tris-(2-carboxyethyl)phosphine
(TCEP), 5% glycerol, pH 8.0. Fractions containing thioredoxin were
pooled, concentrated, and stored at -80 °C.
Procedure for Protein Reaction Purification for NMR
Analysis. After the Mannich reaction, H2NOH·HCl was added to
a final concentration of 100 mM. The solution was mixed for a
minimum of 15 min, although longer mixing times were not
detrimental to the samples. The small molecules were removed from
the protein by three rounds of spin concentration (15 mL, MWCO
10k, prewashed with 0.1 M sodium hydroxide and water to remove
glycerol) into 10 mM phosphate buffer, pH 6.5, to a final volume
of approximately 0.6 mL. The resulting solution was lyophilized
to yield a fluffy white powder. The powder was reconstituted with
deuterium oxide and analyzed by NMR.
NMR Analysis of Protein Conjugates. Single bond couplings
were determined by gradient 1H-13C HSQC performed on a Bruker
AV-500 fitted with an inverse broadband probe in the cases of
chymotrypsinogen A, lysozyme, and papain or a Bruker DRX-500
with inverse triple band probe in the case of thioredoxin.15 The
lysozyme and chymotrypsinogen spectra were signal averaged over
16 h. The papain spectra were signal averaged over 12 h. The
thioredoxin spectrum was signal averaged over 5 days. Multiple
bond couplings on chymotrypsinogen and lysozyme were detected
by 1H-13C CIGAR-HMBC16 experiments, which were signal
averaged over 16 h (lysozyme) or 48 h (chymotrypsinogen). All
protein spectra were acquired at 300 K and calibrated to acetone
1
in 10 mM phosphate, pH 6.5, in D2O: H - δ 2.22, 13C - δ 30.89.
NMR Sample Preparation and Analysis. NMR characterization
of small molecules for comparison to protein conjugates was
performed on a Bruker AV-500 instrument fitted with an inverse
broadband probe. Due to poor solubility in deuterium oxide, small-
molecule models were characterized in organic solvent as noted.
In the case of the tyrosine analogue, 3, and djenkolic acid,
characterization in deuterium oxide with 10 mM phosphate, pH
6.5 was also performed.
Acknowledgment. We thank Prof. Dave Wemmer and Dr. Jeff
Pelton for helpful discussions and donation of instrument time, Prof.
Michael Marletta and Dr. Doug Mitchell for help with thioredoxin,
and Andrew Presley for a generous gift of rTMV coat protein. N.S.J.
gratefully acknowledges the Saegebarth family for generous fel-
lowship support. This work was supported by the NIH (GM072700).
Procedure for Protein Modification for NMR Analysis.
Protein samples for NMR analysis were prepared by the method
first described by Joshi, et al.4 In a 15 mL Falcon tube were
combined 2.0 µmol of chymotrypsinogen, lysozyme, or papain, in
10 mL of 100 mM phosphate buffer, pH 6.5, 34 mg of 4-ami-
nophenethyl alcohol (2) dissolved in 100 µL of DMF, and 30 µL
of 13C-formaldehyde (20% w/w) in water (Cambridge Isotopes).
The solution was mixed gently at room temperature until high levels
of labeling were obtained as estimated by ESI-MS, usually 1-7
days. Although such long reaction times are not typically necessary
for simple protein labeling using this reaction, they were used to
be sure that even minor modification products would be present in
Supporting Information Available: Full experimental proce-
dures and characterization data are available for all compounds.
This material is available free of charge via the Internet at http://
pubs.acs.org.
JA710927Q
(15) Palmer, A. G.; Cavanagh, J.; Wright, P. E.; Rance, M. J. Magn. Reson.
1991, 93, 151–170.
(16) Hadden, C. E.; Martin, G. E.; Krishnamurthy, V. V. Magn. Reson.
Chem. 2000, 38, 143–147.
9
7644 J. AM. CHEM. SOC. VOL. 130, NO. 24, 2008